Recent ADMA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/01/2025 01:02:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2025 01:00:24 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2025 01:00:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2025 01:00:32 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2025 01:00:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 09:25:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2025 05:52:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2025 09:15:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 08:12:24 PM
- ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/07/2025 08:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/30/2025 02:29:28 PM
- ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025 • GlobeNewswire Inc. • 04/30/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2025 11:06:09 AM
- ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process • GlobeNewswire Inc. • 04/28/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2025 01:00:26 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/15/2025 08:40:30 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/15/2025 08:35:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 08:30:32 PM
- ADMA Biologics Statement on Tariffs • GlobeNewswire Inc. • 04/07/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/22/2025 01:00:15 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/20/2025 01:40:41 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2025 08:12:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2025 01:00:26 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM